About Cellmic
Cellmic is a Healthcare company based in Los Angeles (United States) founded in 2009, and was acquired by NOWDiagnostics in July 2018. Rapid test readers are developed for chromatographic and fluorescent assays. Cellmic has raised $5 million across 6 funding rounds from investors including UCLA, HHS and NOWDiagnostics. Its focus areas include Life Sciences, Hematology, In Vitro Diagnostics Tests and Blood Analyzer. Its competitors include Daxor, Essenlix and RizLab Health; 2 of its 3 listed competitors have raised funding.
Company details
Cellmic was founded in 2009 in Los Angeles, United States, and operates in the medical diagnostics sector. Readers for rapid diagnostic tests are produced, including chromatographic and fluorescent versions with integrated smartphones for secure cloud-based data collection. A lens-free holographic microscope and handheld analyzers for blood count, allergens, and mercury contamination are under development. Recognition has been received through awards such as Technology Pioneer 2015 by the World Economic Forum.
- Headquarters Los Angeles, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website cellmic.com
- Acquired by NOWDiagnostics (Jul 2018)
- Total Equity Funding$5M (USD)
in 6 rounds
- InvestorsUCLA
& 4 more
- Acquired byNOWDiagnostics
(Jul 2018)
Funding Insights of Cellmic
Cellmic has successfully raised a total of $5M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5M
- Total Rounds 6
- Investors Count 4
All 6 funding rounds of Cellmic with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2013 | Seed | – | – | ||
| Jan 2012 | $2.5M | Seed | – | – | – |
| Jun 2011 | $2.5M | Seed | – | – | – |
| Jun 2011 | $383,000 | Grant | – | – | |
| May 2011 | $409,507 | Grant | – | – | |
| Jun 2009 | Grant | – | – |
5 investors in total: 5 institutional.
Investors in Cellmic
Cellmic has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include UCLA, HHS and NOWDiagnostics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A challenge by XPRIZE Foundation for health sensing innovation is organized. | nokiasensingxchallenge.org | |||
Research in biomedical imaging and bioengineering is conducted by NIBIB. | nibib.nih.gov | Bethesda, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Undergraduate and postgraduate courses are offered across diversified streams. | 1919 | ucla.edu | United States | |
Develops rapid assay medical tests that use a single drop of blood to test for a variety of common conditions, illnesses and diseases | 2013 | nowdx.com | Bentonville, United States |
Investor details for Cellmic
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Cellmic
4 dated milestones of Cellmic across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Cellmic is founded.
- Funding First funding round.
- Funding Latest funding round, Seed,.
- Exit Acquired by NOWDiagnostics.
Competitors of Cellmic
Cellmic has 3 listed competitors in our database, 2 of them funded. They include Daxor, Essenlix and RizLab Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| daxor.com | 1970 | New York, United States | 22 | Blood volume analyzers are developed by Daxor for diagnostic applications. | ||
| essenlix.com | 2013 | Monmouth Junction, United States | $20M | Mobile health self-test platform is provided using nanotechnology and AI. | ||
| rizlabhealth.com | 2018 | Princeton, United States | $250,000 | An AI-based device for complete blood count analysis is developed. |
Detailed competitors of Cellmic
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Hematology
3 companies that operate in the same segment as Cellmic (Hematology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 300 M | 384 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cellmic
Complete news archive for Cellmic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellmic
Cellmic was founded in 2009.
Cellmic is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Cellmic is a funded company, having raised a total of $5M across 6 funding rounds to date.
Cellmic was founded in 2009 in Los Angeles, United States, and operates in the medical diagnostics sector. Readers for rapid diagnostic tests are produced, including chromatographic and fluorescent versions with integrated smartphones for secure cloud-based data collection. A lens-free holographic microscope and handheld analyzers for blood count, allergens, and mercury contamination are under development. Recognition has been received through awards such as Technology Pioneer 2015 by the World Economic Forum.
Cellmic's top competitors include Daxor, Essenlix and RizLab Health.
Cellmic has 5 investors. Key investors include UCLA, HHS, NOWDiagnostics, Nokia Sensing XCHALLENGE, and National Institute of Biomedical Imaging and Bioengineering.
Yes. Cellmic was acquired by NOWDiagnostics in July 2018.